ChiCTR1900026662Not yet recruitingUnknown
利奈唑胺血清药物谷浓度与药物神经系统毒性作用的相关性研究
扬帆基金、自筹基金1 site in 1 country60 target enrollmentStarted: October 1, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- 药物谷浓度
Study Overview
Brief Summary
利奈唑胺药物谷浓度水平与神经系统不良反应之间相关性研究。
Study Design
- Study Type
- Other
- Primary Purpose
- 连续入组
- Masking
- N/a
Eligibility Criteria
- Ages
- 18 to 75 (—)
- Sex
- All
Inclusion Criteria
- •服用利奈唑胺治疗耐多药结核病超过半年的病人。
Exclusion Criteria
- Not provided
Arms & Interventions
观察组
药物浓度监测
Outcomes
Primary Outcomes
药物谷浓度
神经毒性
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
利奈唑胺在中国健康受试者药代动力学试验研究ChiCTR-ONRC-10000751国家十一五重大专项课题24
Unknown
Not Applicable
肾衰 CRRT 患者利奈唑胺血液与唾液浓度相关性研究肾衰竭ChiCTR-OO-14004876自费20
Unknown
Not Applicable
利奈唑胺在肝功能不全患者中的群体药动学研究及给药方案优化ChiCTR1900022118个人科研经费60
Recruiting
Unknown
肝功能不全患者伏立康唑治疗药物监测和安全性研究ChiCTR1800019334个人科研经费80
Unknown
Not Applicable
利奈唑胺在重症感染患者的群体药代 / 药效动力学研究ChiCTR-RNC-10000762国家十一五科技重大专项课题100